Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African American Ethnicity

被引:20
作者
Babaoglu, Hakan [1 ,2 ]
Li, Jessica [1 ]
Goldman, Daniel [1 ]
Magder, Laurence S. [3 ]
Petri, Michelle [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
[2] Gazi Univ, Sch Med, Ankara, Turkey
[3] Univ Maryland, Baltimore, MD 21201 USA
关键词
MULTIETHNIC US COHORT; INITIAL VALIDATION; REVISED CRITERIA; DAMAGE INDEX; ERYTHEMATOSUS; LUMINA; NEPHRITIS; SURVIVAL; HYDROXYCHLOROQUINE; CLASSIFICATION;
D O I
10.1002/acr.24063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Lupus low disease activity state (LLDAS) is a potential treat-to-target goal in systemic lupus erythematosus (SLE). This study determined predictors of time to reach LLDAS in a longitudinal cohort. Methods Patients were grouped according to LLDAS status at cohort entry. Those who did not satisfy LLDAS at cohort entry were analyzed prospectively. The Kaplan-Meier approach was used to estimate the time to LLDAS. Cox regression was used to identify patient characteristics that were associated with time to LLDAS. Results The probability of LLDAS attainment within 1 year was 52% for Caucasians, 36% for African Americans, and 33% for SLE patients with renal involvement. The median time to LLDAS was 1.1 years. In multivariable models, African American ethnicity, baseline prednisone >10 mg daily, hypocomplementemia, baseline damage, and baseline renal activity remained significant predictors of longer time to attain LLDAS, while disease duration LLDAS is potentially attainable in the majority of SLE patients. The time to LLDAS was found to be longer in African American patients with SLE. Characteristics of African American patients with SLE, such as renal activity and hypocomplementemia, were also independent predictors of slower attainment of LLDAS. These findings point to the need to include African American patients with SLE in both clinical and pharmaceutical research.
引用
收藏
页码:225 / 232
页数:8
相关论文
共 52 条
  • [1] Systemic lupus erythematosus in a multiethnic cohort:: LUMINA XXXV.: Predictive factors of high disease activity over time
    Alarcon, G. S.
    Calvo-Alen, J.
    McGwin, G., Jr.
    Uribe, A. G.
    Toloza, S. M. A.
    Roseman, J. M.
    Fernandez, M.
    Fessler, B. J.
    Vila, L. M.
    Ahn, C.
    Tan, F. K.
    Reveille, J. D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (09) : 1168 - 1174
  • [2] Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus:: Data from LUMINA, a multiethnic US cohort (LUMINA L)
    Alarcon, Graciela S.
    McGwin, Gerald
    Bertoli, Ana M.
    Fessler, Barri J.
    Calvo-Alen, Jaime
    Bastian, Holly M.
    Vila, Luis M.
    Reveille, John D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) : 1168 - 1172
  • [3] Alarcón GS, 1998, ARTHRITIS RHEUM-US, V41, P1173, DOI 10.1002/1529-0131(199807)41:7<1173::AID-ART5>3.0.CO
  • [4] 2-A
  • [5] Alarcón GS, 2001, ARTHRITIS RHEUM, V44, P2797, DOI 10.1002/1529-0131(200112)44:12<2797::AID-ART467>3.0.CO
  • [6] 2-9
  • [7] Systemic lupus erythematosus in three ethnic groups:: III A comparison of characteristics early in the natural history of the LUMINA cohort
    Alarcón, GS
    Friedman, AW
    Straaton, KV
    Moulds, JM
    Lisse, J
    Bastian, HM
    McGwin, G
    Bartolucci, AA
    Roseman, JM
    Reveille, JD
    [J]. LUPUS, 1999, 8 (03) : 197 - 209
  • [8] Baseline characteristics of a multiethnic lupus cohort:: PROFILE
    Alarcón, GS
    McGwin, G
    Petri, M
    Reveille, JD
    Ramsey-Goldman, R
    Kimberly, RP
    [J]. LUPUS, 2002, 11 (02) : 95 - 101
  • [9] Mortality in systemic lupus erythematosus
    Bernatsky, S.
    Boivin, J. -F.
    Joseph, L.
    Manzi, S.
    Ginzler, E.
    Gladman, D. D.
    Urowitz, M.
    Fortin, P. R.
    Petri, M.
    Barr, S.
    Gordon, C.
    Bae, S. -C.
    Isenberg, D.
    Zoma, A.
    Aranow, C.
    Dooley, M. -A.
    Nived, O.
    Sturfelt, G.
    Steinsson, K.
    Alarcon, G.
    Senecal, J. -L.
    Zummer, M.
    Hanly, J.
    Ensworth, S.
    Pope, J.
    Edworthy, S.
    Rahman, A.
    Sibley, J.
    El-Gabalawy, H.
    McCarthy, T.
    Pierre, Y. St.
    Clarke, A.
    Ramsey-Goldman, R.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (08): : 2550 - 2557
  • [10] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640